Trevor Johnson, MD
Pain Medicine · New Orleans, LANPI 1023501707
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $7,829 of the $10,526 with a category attached, or 74.4%. 17 manufacturers reported payments, led by Abbott at 49.5% of the total. Reporting peaked in 2023 at $4,855 and has fallen 79.4% since, to $1,003 in 2025.
Across 83 payments — averaging $126.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$5K
- Stryker$2K
- Surgentec$1K
- Spinal Simplicity, LLC$1K
- Stratus Medical, LLC$344
- SPR Therapeutics, Inc$174
- plus $607 from 11 others
What the payments were for
- Travel & lodging$7,82974%
- Food & beverage$2,69726%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 27 | $5,208 |
| Stryker | 11 | $1,855 |
| Surgentec | 1 | $1,209 |
| Spinal Simplicity, LLC | 14 | $1,130 |
| Stratus Medical, LLC | 2 | $344 |
| SPR Therapeutics, Inc | 5 | $174 |
| Collegium Pharmaceutical, Inc. | 8 | $166 |
| Saluda Medical Americas, Inc. | 2 | $125 |
| Nevro Corp. | 3 | $83 |
| Boston Scientific | 2 | $67 |
| Biotronik NRO, Inc. | 1 | $42 |
| AbbVie | 2 | $39 |
| Medtronic | 1 | $21 |
| Hydrocision, Inc. | 1 | $20 |
| Globus Medical | 1 | $16 |
| Vertex | 1 | $15 |
| Scilex Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$4,452
- ION$1,209
- TiLink$1,209
- SPINEJACK$1,152
- HA MINUTEMAN G3-R$914
- OPTABLATE$801
- mild Device Kit$442
- Nimbus$344
- ETERNA$242
How this compares
$10,526 in reported general payments places this provider in the 85th percentile of 97 pain medicine providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 427 | $11,165 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 263 | $6,703 |
| Celecoxib | 340 | $4,469 |
| Pregabalin | 228 | $3,395 |
| Tizanidine Hcl | 455 | $2,896 |
| Gabapentin | 189 | $2,861 |
| Diclofenac Sodium | 69 | $1,506 |
| Lidocaine | 16 | $1,269 |
| Methocarbamol | 61 | $1,083 |
| Tramadol Hcl | 137 | $995 |
| Duloxetine Hcl | 53 | $673 |
| Cyclobenzaprine Hcl | 66 | $591 |
| Baclofen | 23 | $497 |
| Amitriptyline Hcl | 35 | $483 |
| Methylprednisolone | 24 | $163 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in New Orleans
- Alan KayeNew Orleans$76K
- Hazem EissaNew Orleans$50K
- Robert OwensNew Orleans$47K
- Yashar EshraghiNew Orleans$22K
- Aaron Hanyu-DeutmeyerNew Orleans$17K
- Eric RoysterNew Orleans$10K
- Lesley WalshNew Orleans$10K
- Alvah WickboldtNew Orleans$7K
- Arya BekhradiNew Orleans$6K
- Reda TolbaNew Orleans$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.